<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   3694
  </number>
  <updateDate>
   2023-03-08T20:12:35Z
  </updateDate>
  <updateDateIncludingText>
   2023-03-08T20:12:35Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-06-04
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 97 (Friday, June 4, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. CARTER of Georgia:H.R. 3694.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the U.S. Constitution[Page H2693]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hswm00
    </systemCode>
    <name>
     Ways and Means Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-06-04T13:36:20Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <actions>
   <item>
    <actionDate>
     2021-06-04
    </actionDate>
    <text>
     Referred to the House Committee on Ways and Means.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hswm00
      </systemCode>
      <name>
       Ways and Means Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-06-04
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-06-04
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     C001103
    </bioguideId>
    <fullName>
     Rep. Carter, Earl L. "Buddy" [R-GA-1]
    </fullName>
    <firstName>
     Earl
    </firstName>
    <lastName>
     Carter
    </lastName>
    <party>
     R
    </party>
    <state>
     GA
    </state>
    <middleName>
     L. "Buddy"
    </middleName>
    <district>
     1
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <policyArea>
   <name>
    Foreign Trade and International Finance
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Cardiovascular and respiratory health
     </name>
    </item>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Emergency medical services and trauma care
     </name>
    </item>
    <item>
     <name>
      Government information and archives
     </name>
    </item>
    <item>
     <name>
      Health care coverage and access
     </name>
    </item>
    <item>
     <name>
      Health technology, devices, supplies
     </name>
    </item>
    <item>
     <name>
      Immunology and vaccination
     </name>
    </item>
    <item>
     <name>
      Infectious and parasitic diseases
     </name>
    </item>
    <item>
     <name>
      Intellectual property
     </name>
    </item>
    <item>
     <name>
      Manufacturing
     </name>
    </item>
    <item>
     <name>
      Product development and innovation
     </name>
    </item>
    <item>
     <name>
      Research and development
     </name>
    </item>
    <item>
     <name>
      Trade agreements and negotiations
     </name>
    </item>
    <item>
     <name>
      World health
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Foreign Trade and International Finance
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-06-04
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2022-01-14T17:04:59Z
    </updateDate>
    <text>
     &lt;p&gt;This bill requires the Department of Health and Human Services (HHS) to submit a report analyzing the impact on global COVID-19 vaccine access of a waiver of certain obligations held by nations who are members of the Agreement on Trade-Related Aspects of Intellectual Property Rights. (India and South Africa previously submitted a petition to suspend all intellectual property rights associated with COVID-19 innovations, such as vaccines.)&lt;/p&gt; &lt;p&gt;Based on this report, the U.S. Trade Representative must oppose such elimination or waiver with respect to COVID-19 vaccines if HHS determines that the elimination or waiver will not materially increase global vaccine access or that it will have a negative impact on specified factors relating to access to, manufacture of, and investment in COVID-19 vaccines.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-06-04T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr3694ih/xml/BILLS-117hr3694ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-06-04
   </actionDate>
   <text>
    Referred to the House Committee on Ways and Means.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

H11100
2021-06-04
Ways and Means Committee
hswm00
2
House floor actions
Referred to the House Committee on Ways and Means.
IntroReferral
Intro-H
2021-06-04
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-06-04
9
Library of Congress
Introduced in House
IntroReferral
2021-06-04T13:36:20Z
Referred to
House
Ways and Means Committee
hswm00
Standing
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-06-04
2021-06-04
Referred to the House Committee on Ways and Means.
House
Foreign Trade and International Finance
C001103
1
Earl
Rep. Carter, Earl L. "Buddy" [R-GA-1]
N
Carter
L. "Buddy"
R
GA
Cardiovascular and respiratory health Congressional oversight Emergency medical services and trauma care Government information and archives Health care coverage and access Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Intellectual property Manufacturing Product development and innovation Research and development Trade agreements and negotiations World health
2021-06-04
Introduced in House
 <p>This bill requires the Department of Health and Human Services (HHS) to submit a report analyzing the impact on global COVID-19 vaccine access of a waiver of certain obligations held by nations who are members of the Agreement on Trade-Related Aspects of Intellectual Property Rights. (India and South Africa previously submitted a petition to suspend all intellectual property rights associated with COVID-19 innovations, such as vaccines.)</p> <p>Based on this report, the U.S. Trade Representative must oppose such elimination or waiver with respect to COVID-19 vaccines if HHS determines that the elimination or waiver will not materially increase global vaccine access or that it will have a negative impact on specified factors relating to access to, manufacture of, and investment in COVID-19 vaccines.</p>
2022-01-14T17:04:59Z
00
2021-06-04T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr3694ih/xml/BILLS-117hr3694ih.xml
To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
Display Title
IH
Introduced in House
To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
Official Title as Introduced
HR
2023-03-08T20:12:35Z
2023-03-08T20:12:35Z
3.0.0
H11100
2021-06-04
Ways and Means Committee
hswm00
2
House floor actions
Referred to the House Committee on Ways and Means.
IntroReferral
Intro-H
2021-06-04
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-06-04
9
Library of Congress
Introduced in House
IntroReferral
C001103
1
Earl
Rep. Carter, Earl L. "Buddy" [R-GA-1]
N
Carter
L. "Buddy"
R
GA
Cardiovascular and respiratory health Congressional oversight Emergency medical services and trauma care Government information and archives Health care coverage and access Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Intellectual property Manufacturing Product development and innovation Research and development Trade agreements and negotiations World health
2021-06-04
Introduced in House
 <p>This bill requires the Department of Health and Human Services (HHS) to submit a report analyzing the impact on global COVID-19 vaccine access of a waiver of certain obligations held by nations who are members of the Agreement on Trade-Related Aspects of Intellectual Property Rights. (India and South Africa previously submitted a petition to suspend all intellectual property rights associated with COVID-19 innovations, such as vaccines.)</p> <p>Based on this report, the U.S. Trade Representative must oppose such elimination or waiver with respect to COVID-19 vaccines if HHS determines that the elimination or waiver will not materially increase global vaccine access or that it will have a negative impact on specified factors relating to access to, manufacture of, and investment in COVID-19 vaccines.</p>
2022-01-14T17:04:59Z
00
To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
Display Title
IH
Introduced in House
To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
Official Title as Introduced
2021-06-04
Referred to the House Committee on Ways and Means.